Physician

Jamie L Odden

According to 2025 Medicare claims, Jamie Odden (NPI: 1427588698) practices ophthalmology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is EYE ASSOCIATES OF NEW MEXICO LTD (NPI: 1104868520; TIN: 85-0246856) and primary practice location at 87113-2474. Odden is affiliated with the Innovation Care Partners MSSP (ACO ID: A2029), participating under the MSSP model.

Odden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 777 traditional Medicare patients, billed 49,588 HCPCS/CPT codes, and received $2,282,857 in Medicare payments. The top billing code was J2778 (Injection, ranibizumab, 0.1 mg). Part D data shows 411 prescription claims across 155 beneficiaries totaling $17,838 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 22 records totaling $883. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $215 to $17,838. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2021 Medicare payment: $3,096 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $26,182 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $625,329 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,282,857 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211530$3,096
2022157220$26,182
202350212,584$625,329
202477749,588$2,282,857

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$8.9K$18K2017 Drug cost: $215 (USD; Tot_Drug_Cst)2018 Drug cost: $2,204 (USD; Tot_Drug_Cst)2021 Drug cost: $2,347 (USD; Tot_Drug_Cst)2022 Drug cost: $4,236 (USD; Tot_Drug_Cst)2023 Drug cost: $5,385 (USD; Tot_Drug_Cst)2024 Drug cost: $17,838 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R13$215
20182047$2,204
2019N/RN/RN/R
2020N/RN/RN/R
20211930$2,347
20224990$4,236
202357102$5,385
2024155411$17,838

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J2778Injection, ranibizumab, 0.1 mg1512,687$125
92004New patient complete exam of visual system265265$92
67028Injection of drug into eye3221,269$89
92014Established patient complete exam of visual system537883$83
92134Imaging of retina6771,265$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1404,505$5,395
OfloxacinOfloxacin742,275$917
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat493,383$804
Ketorolac TromethamineKetorolac Tromethamine19575$600
Brimonidine TartrateBrimonidine Tartrate17653$435

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.22$883Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jamie L. Odden?

Tedicare shows public-source Medicare data for Jamie L. Odden (NPI 1427588698), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamie L. Odden have ACO affiliation data?

Jamie L. Odden is shown with ACO affiliation data for Innovation Care Partners MSSP (MSSP, ACO ID A2029).

What billing organization is linked to Jamie L. Odden?

Jamie L. Odden is linked to EYE ASSOCIATES OF NEW MEXICO LTD (billing NPI 1104868520) in the available physician profile data.

Does Jamie L. Odden have Open Payments data?

Jamie L. Odden has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.